Baxter (NYSE: BAX) surgery chief lists common shares and option grants

Rhea-AI Filing Summary

Baxter International executive Steven P. Wallace, President of Advanced Surgery, reported his initial holdings on a Form 3. He directly owns 70,282 shares of common stock and holds several stock option awards covering additional shares at exercise prices between $20.37 and $74.47 with expirations from 2032 through 2036.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Wallace Steven P.

Role President, Adv. Surgery

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Common Stock, $1 par value	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 8,918 shares (Direct); Common Stock, $1 par value — 70,282 shares (Direct)

Footnotes (1)

1. The options became exercisable in three equal annual installments beginning on June 1, 2023, the first anniversary of the grant date. The options became exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date. The options became exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date. The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.

Key Figures

Direct common shares: 70,282 shares Option grant 1: 8,918 shares at $74.47 Option grant 2: 15,352 shares at $39.06 +2 more

5 metrics

Direct common shares 70,282 shares Directly held Baxter common stock as reported on Form 3

Option grant 1 8,918 shares at $74.47 Stock option, expires June 1, 2032

Option grant 2 15,352 shares at $39.06 Stock option, expires March 1, 2033

Option grant 3 17,840 shares at $35.44 Stock option, expires March 6, 2035

Option grant 4 25,862 shares at $20.37 Stock option, expires February 27, 2036

Key Terms

Stock Option (Right to Buy), Common Stock, $1 par value, exercisable in three equal annual installments, exercise price

4 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)" for multiple entries"

Common Stock, $1 par value financial

"underlying_security_title: "Common Stock, $1 par value""

exercisable in three equal annual installments financial

"The options became exercisable in three equal annual installments beginning on June 1, 2023"

exercise price financial

"conversion_or_exercise_price values such as "74.4700" and "20.3700""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wallace Steven P.

(Last) (First) (Middle)

ONE BAXTER PARKWAY

(Street)

DEERFIELD ILLINOIS 60015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026

3. Issuer Name and Ticker or Trading Symbol
BAXTER INTERNATIONAL INC [ BAX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Adv. Surgery

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $1 par value	70,282	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	06/01/2032	Common Stock, $1 par value	8,918	$74.47	D
Stock Option (Right to Buy)	(2)	03/01/2033	Common Stock, $1 par value	15,352	$39.06	D
Stock Option (Right to Buy)	(3)	03/06/2035	Common Stock, $1 par value	17,840	$35.44	D
Stock Option (Right to Buy)	(4)	02/27/2036	Common Stock, $1 par value	25,862	$20.37	D

Explanation of Responses:

1. The options became exercisable in three equal annual installments beginning on June 1, 2023, the first anniversary of the grant date.

2. The options became exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.

3. The options became exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date.

4. The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.

Remarks:

	/s/ Kimberly Olson, as attorney in-fact for Steven P. Wallace	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Steven P. Wallace’s Form 3 for Baxter (BAX) report?

The Form 3 reports Steven P. Wallace’s initial ownership in Baxter. It shows directly held common stock plus multiple stock option grants with specified exercise prices and long-dated expirations, establishing his baseline equity position as President of Advanced Surgery.

How many Baxter (BAX) common shares does Steven P. Wallace hold?

Steven P. Wallace directly holds 70,282 shares of Baxter common stock. This figure represents his reported baseline equity stake in the company’s common stock, separate from any additional shares that could be obtained through his outstanding stock option awards.

What stock options are reported for Steven P. Wallace in Baxter (BAX)?

The filing lists several stock option awards, each giving rights to buy Baxter common stock at fixed prices. These options cover 8,918 shares at $74.47, 15,352 at $39.06, 17,840 at $35.44, and 25,862 at $20.37, all held directly.

When do Steven P. Wallace’s Baxter (BAX) stock options expire?

The reported Baxter stock options have staggered expiration dates. They expire on June 1, 2032; March 1, 2033; March 6, 2035; and February 27, 2036, providing a long-term window during which Wallace can choose to exercise them.

How do Steven P. Wallace’s Baxter (BAX) options vest according to the footnotes?

The footnotes state each option grant becomes exercisable in three equal annual installments. Vesting begins on the first anniversary of the respective grant dates, such as June 1, 2023 or March 1, 2024, spreading Wallace’s ability to exercise over several years.